Epidemiology of Helicobacter pylori and gastric cancer

被引：74

作者：

Kikuchi S. ^{[1
]}

机构：

[1] Department of Public Health, Aichi Medical University, School of Medicine, Aichi 480-1195, 21 Karimata, Yazako, Nagakute-cho

来源：

Gastric Cancer | 2002年 / 5卷 / 1期

关键词：

Esophageal adenocarcinoma; Helicobacter pylori; Prevention for gastric cancer;

D O I：

10.1007/s101200200001

中图分类号：

学科分类号：

摘要：

Findings in epidemiological studies of the relationship between Helicobacter pylori and gastric cancer have been inconsistent: many studies have yielded a positive relationship, whereas several studies have shown no relationship. The inconsistency arises because of the occurrence of seroreversion during the period between the time that H. pylori exerts a carcinogenic effect and the time of blood sampling. When this seroreversion is taken into account, there is an epidemiologically positive association between H. pylori status and the risk for gastric cancer. In addition to the epidemiological evidence, experimental studies using Mongolian gerbils have shown that H. pylori infection elevates the risk for gastric cancer. It is concluded that H. pylori is a causal factor for gastric cancer. In the creation of preventive strategies against gastric cancer by the eradication of H. pylori, determination of the time at which H. pylori plays a role as a carcinogen is important. Three hypotheses have been proposed in regard to this timing: that H. pylori infection in childhood or the teenage years acts as a factor that produces precancerous lesions with irreversible damage in the gastric mucosa, that in adulthood it acts as an initiator, and also in adulthood, that it acts as a promoter. As these hypotheses are not mutually exclusive, the extent to which each hypothesis plays a part in explaining gastric carcinogenesis should be evaluated. Only a small proportion of subjects infected with H. pylori have gastric cancer during their lifetime. Interleukin-1 polymorphism, a host factor, and CagA, a virulence factor of H. pylori, are suspected to be risk factors for gastric cancer in subjects with H. pylori infection. Dietary factors, especially vitamin C, and patterns of precancerous lesions also seem to influence the relationship between H. pylori and gastric cancer. H. pylori seems to reduce the risk for esophageal and for some gastric cardia adenocarcinomas. This finding, as well as determination of the time at which H. pylori exerts this preventive effect, should be considered in the creation of preventive strategies against gastric cancer that target the eradication of H. pylori.

引用

页码：6 / 15

页数：9

共 103 条

[91]

Jedrychowski W., Popiela T., Drews M., Gabryelewicz A., Marlicz K., Misiunia P., Et al., Effect of Helicobacter pylori infection, smoking and dietary habits on the occurrence of antrum intestinal metaplasia. Clinico-epidemiological study in Poland, Pol J Pathol, 50, pp. 289-295, (1999)

[92]

Correa P., Fontham E.T., Bravo J.C., Bravo L.E., Ruiz B., Zarama G., Et al., Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy, J Natl Cancer Inst, 92, pp. 1881-1888, (2000)

[93]

You W.C., Zhang L., Gail M.H., Chang Y.S., Liu W.D., Ma J.L., Et al., Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors, J Natl Cancer Inst, 92, pp. 1607-1612, (2000)

[94]

Chow W.H., Blaser M.J., Blot W.J., Gammon M.D., Vaugan T.L., Risch H.A., Et al., An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma, Cancer Res, pp. 588-590, (1998)

[95]

Weston A.P., Badr A.S., Topalovski M., Cherian R., Dixon A., Hassanein R.S., Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma, Am J Gastroenterol, 95, pp. 387-394, (2000)

[96]

Oberg S., Peters J.H., Nigro J.J., Theisen J., Hagen J.A., DeMeester S.R., Et al., Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease, Arch Surg, 134, pp. 722-726, (1999)

[97]

Vaezi M.F., Falk G.W., Peek R.M., Vicari J.J., Goldblum J.R., Perez-Perez G.I., Et al., CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus, Am J Gastroenterol, 95, pp. 2206-2211, (2000)

[98]

Loffeld R.J., Werdmuller B.F., Kuster J.G., Perez-Perez G.I., Blaser M.J., Kuipers E.J., Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus, Digestion, 62, pp. 95-99, (2000)

[99]

Falk G.W., Gastroesophageal reflux disease and Barrett's esophagus, Endoscopy, 33, pp. 109-118, (2001)

[100]

Devesa S.S., Blot W.J., Fraumeni J.F. Jr., Changing patterns in the incidence of esophageal and gastric carcinoma in the United States, Cancer, 83, pp. 2049-2053, (1998)

← 2 3 4 5 6 7 8 9 10 11 →